Camille L. Bedrosian, EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 7,500 shares at $100.03 ($751K) on 2021-09-01, disclosed to the SEC on 2021-09-02.
Open-market sale of $751k RARE by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.03 | 2,500 | $250K | 33.3% |
| 2 | $100.18 | 2,500 | $250K | 33.3% |
| 3 | $100.18 | 2,500 | $250K | 33.3% |
| Total | $100.13 avg | 7,500 | $751K | 100% |
| Filing → |
| AMLX | SELL | 2025-12-03 | $94K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $351K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |